Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Jan Hlavsa"'
Autor:
Lumír Kunovský, Petr Dítě, Petr Jabandžiev, Michal Eid, Karolina Poredská, Jitka Vaculová, Dana Sochorová, Pavel Janeček, Pavla Tesaříková, Martin Blaho, Jan Trna, Jan Hlavsa, Zdeněk Kala
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 24, p 5779 (2021)
Exocrine pancreatic insufficiency (EPI), an important cause of maldigestion and malnutrition, results from primary pancreatic disease or is secondary to impaired exocrine pancreatic function. Although chronic pancreatitis is the most common cause of
Externí odkaz:
https://doaj.org/article/7a9734d2a4404d6b96cc721a42827a96
Autor:
Natalia Gablo, Karolina Trachtova, Vladimir Prochazka, Jan Hlavsa, Tomas Grolich, Igor Kiss, Josef Srovnal, Alona Rehulkova, Martin Lovecek, Pavel Skalicky, Ioana Berindan-Neagoe, Zdenek Kala, Ondrej Slaby
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 8, p 2440 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal and aggressive cancers with a less than 6% five-year survival rate. Circulating microRNAs (miRNAs) are emerging as a useful tool for non-invasive diagnosis and prognosis estimation in
Externí odkaz:
https://doaj.org/article/6660e24adfd5417ea64f8f485c51a916
Publikováno v:
Gastroenterologie a hepatologie. 76:212-217
ntroduction: Postoperative pancreatic fistula (POPF) is one of the most serious complications in pancreatobiliary surgery. The management of clinically relevant grade B and C fistulas requires interventional management or reoperation. POPF is accompa
Autor:
Jan Hlavsa, Jiří Mayer, Zdeněk Kala, Ivana Kosíková, Ondřej Slabý, Dagmar Brančíková, Lenka Ostřížková, Pavel Janeček, Lumír Kunovský, Michal Eid, Monika Blažková
Publikováno v:
Neoplasma. 68:1-9
Pancreatic ductal adenocarcinoma (PDAC) is now the 11th most common cancer and in 2018 there were 458,918 new cases worldwide. In the Czech Republic, a total of 2,173 patients were diagnosed in 2015, ranking the second in incidence worldwide. In cont
Autor:
Martin Potrusil, Petr Raušer, Zdeněk Kala, Tomáš Grolich, Michal Crha, Tomáš Andrašina, Jan Hlavsa
Publikováno v:
Acta Veterinaria Brno. 88:287-290
The main aim of this study was to find a standardized method for preventive stenting of biliary tract anastomosis with biodegradable self-expandable stent from polydioxanone and to evaluate the functionality of the stent. The experimental study was c
Autor:
Pavel Skalicky, Vladimír Procházka, Tomáš Grolich, Zdenek Kala, Jan Hlavsa, Karolina Trachtova, Josef Srovnal, Martin Lovecek, Ondrej Slaby, Ioana Berindan-Neagoe, Natalia Anna Gablo, Igor Kiss, Alona Rehulkova
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2440, p 2440 (2020)
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2440, p 2440 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal and aggressive cancers with a less than 6% five-year survival rate. Circulating microRNAs (miRNAs) are emerging as a useful tool for non-invasive diagnosis and prognosis estimation in
Publikováno v:
Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti. 98(11)
Introduction: Clinical study evaluating the impact of intraoperative radiofrequency ablation in pancreatic cancer. Methods: Patients with histologically proved pancreatic cancer were included. Two groups were defined. In the RFA group (n=24) intraope
Autor:
Vladimír Procházka, Jan Hlavsa, Zdenek Kala, Tomáš Pavlík, Lumir Kunovsky, Jan Mazanec, L Ostrizkova, Alexandra Litavcová, Michal Eid, Martina Farkašová, Petra Kovalcikova, Tomáš Andrašina, Jiří Dolina, Martin Potrusil
Publikováno v:
Neoplasma. 67(6)
Pancreatic carcinoma is an aggressive tumor with a grim prognosis. Accurate staging is essential for indicating surgery in patients with borderline resectable tumors. This paper examines the correlation between pre-operation characteristics of tumors
Autor:
Tomáš Pavlík, Zdeněk Kala, F. Cecka, Jan Hlavsa, Martin Lovecek, J. Zajak, R. Strnad, P. Zaruba, R. Gurlich
Publikováno v:
Neoplasma. 65:637-643
Aim of the study was to asses the tumor grade prognostic value in the Czech pancreatic cancer patients and to evaluate the accuracy of TNMG prognostic model. Retrospective analysis of 431 pancreatic cancer patients undergoing pancreatic resection in
Autor:
Petra Vychytilova-Faltejskova, Markéta Hermanová, Igor Kiss, Zdenek Kala, Vladimír Procházka, Natalia Anna Gablo, Jan Hlavsa, Ondrej Slaby, Petr Karasek
Publikováno v:
Cancer Genomics - Proteomics. 15:321-327
Blood plasma microRNAs (miRNAs) are emerging as a clinically useful tool for non-invasive detection and prognosis estimation in various cancer types including pancreatic ductal adenocarcinoma (PDAC). The aim of the present study was to provide an ind